| Document |
Document Title |
|
WO/2004/039993A1 |
The present invention relates to a polynucleotide sequence encoding a pyranosone dehydratase. The present invention further relates to a method for producing transgenic plants which are resistant to pathogens, particularly fungal pathoge...
|
|
WO/2004/039820A1 |
The present invention provides an antimicrobial material comprising (i) an antimicrobial compound in a stabilised form (a 'stabilised compound'), or (ii) (a) a first conversion agent capable of converting a precursor of an antimicrobial ...
|
|
WO/2004/031244A1 |
The present invention is directed to novel methods to produce carbohydrate polymers and oligomers especially for pharmaceutical and food industries. The invention is directed to methods to remodel monosaccharides, and/or oligosaccharides...
|
|
WO/2004/031202A2 |
The invention relates to methods for producing condensed palatinose in hydrogenated form, to hydrogenated condensed palatinose produced thereby, to uses of this palatinose, and to foodstuffs and medicaments containing hydrogenated conden...
|
|
WO/2004/027076A2 |
Biodegradable polyesters are produced by microbial fermentation using xylose and levulinic acid as carbon sources.
|
|
WO/2004/026317A1 |
It is intended to provide a histamine release inhibitor which contains, as the active ingredient, pectin or its salt or a pectin hydrolysate; and medicinal compositions, cosmetics, foods and drinks containing this inhibitor.
|
|
WO2003018766A9 |
The invention provides polynuc1eotides, preferably synthetic polynucleotides, which encode processing enzymes that are optimized for expression in plants. The polynucleotides encode mesophilic, thermophilic, or hyperthermophi1ic processi...
|
|
WO/2004/017810A2 |
The present invention describes oligosaccharide sequences, which are specifically expressed by human tumors. The present invention is related to a method of determining an oligosaccharide sequence, which comprises a tumor specific termin...
|
|
WO/2004/016789A1 |
A method of modifying a sugar chain of a sugar chain-binding protein; a sugar chain-binding protein having a modified sugar chain; cells expressing a modified sugar chain-binding protein and a method of constructing the same; and a proce...
|
|
WO/2004/016626A2 |
Methods for forming structurally defined organosilicon carbohydrates are provided. Additionally, structurally defined organosilicon carbohydrates are provided. The structurally defined organosilicon carbohydrates may be formed by contact...
|
|
WO/2004/013151A2 |
Multiple strains and species of Campylobacter were found to share a common glycan moitie which is present in a plurality of surface-exposed glycoproteins. This glycan has the formula: GalNAc-a1,4-GalNAc-a1,4-[Glc-ß1,3]GalNAc-a1,4-GalNAc...
|
|
WO/2004/007513A1 |
The present invention relates to a economic synthetic method of 2-deoxy-L-ribose from 2-deoxy-D-ribose with easy reaction, separation and purification. The present invention consists of four(4) steps including protection, activation 3-an...
|
|
WO/2003/106472A1 |
The invention relates to a novel palatinose condensation product which is obtained by condensing the disaccharide palatinose in a molten mass of palatinose, water and an organic acid.
|
|
WO/2003/106471A1 |
A method for the combinatorial synthesis of oligosaccharides comprising the steps of: (i) conjugating a saccharide building block containing orthogonally protected functional groups to a solid support, the protection being via at least o...
|
|
WO/2003/104473A2 |
The invention relates to a method for production of galactosyl isomalt and galactosyl isomalt, the products and intermediate products obtained and the use thereof.
|
|
WO/2003/101464A1 |
It is intended to provide an antiinflammatory agent made from a highly safe material which can be daily taken as a food, an agent for preventing or ameliorating allergic diseases and a functional food having the above effects. The antiin...
|
|
WO/2003/101578A1 |
A crystalline material sufficiently pure for use in pharmaceuticals may be made by forming a saturated solution of the material, changing the temperature of the solution so it becomes supersaturated, and subjecting the solution to irradi...
|
|
WO/2003/097208A1 |
The invention relates to an equipment for fractionating a solution by a sequential SMB process, which equipment comprises a feed column and one or several other columns, which include a chromatographic separation resin bed. The equipment...
|
|
WO/2003/093286A1 |
Methods are described for the preparation of combinatorial libraries of potentially biologically active disaccharide compounds. These compounds are variously functionalized, with a view to varying lipid solubility size, function and othe...
|
|
WO/2003/089420A2 |
This invention concerns a process for recovering and purifying dianhydro sugar alcohols from a vapor stream comprising dianhydro sugar alcohols, such as isosorbide, and water vapor.
|
|
WO/2003/089435A1 |
A process for recycling reaction byproducts in the manufacture of dianhydro sugar alcohols, such as isosorbide, from corresponding sugar alcohols.
|
|
WO/2003/086612A1 |
The present invention relates to a method of producing a dynamic combinatorial library of chemical compounds. In particular, the present invention relates to a method of producing a dynamic combination of compounds containing at least on...
|
|
WO/2003/085139A1 |
The present invention pertains to a chromatographic process for separating saccharide monomers from dimers and/or saccharide trimers from dimers. The separation is effected with a cation exchange resin. If saccharide monomers are separat...
|
|
WO/2003/074570A1 |
It is intended to provide novel branched sialo-sugar molecules represented by the following general formula (I) as substances which respond to variations in the host area of influenza viruses as well as variations in antigenicity and are...
|
|
WO/2003/071085A2 |
The invention provides an organic diacid anhydride-modified chitosan containing a polar additive comprising water soluble compounds containing one or more hydroxyl groups or one or more amino groups, including compounds containing both h...
|
|
WO/2003/068243A1 |
A process and cosmetic preparation for skin augmentation of a subject comprising an active component comprising a 1,4 linked D−glucose oligosaccharide or polysaccharide wherein after delivery, the oligosaccaharide or polysaccharide cau...
|
|
WO/2003/063881A1 |
The invention relates to a dose of 2.5 mg of the pentasaccharide methyl O−(2,3,4−tri−O−methyl−6−O−sulfo−&agr −D−glucopyranosyl)−(1→4)−O−(2,3−di−O−methy
l−β−D−glucopyranosyl uronic acid)−(1→4)â...
|
|
WO2003016577B1 |
Crystalline fructose, from sugar cane sucrose, having particles composed of microcrystals which exhibit a narrow size distribution with a mean diameter of 250 to 350 microns. A process comprising: chemical conversion of sucrose by acid h...
|
|
WO/2003/062314A1 |
The invention relates to methods of making carbohydrate and polyol esters suitable for use as plasticizers for polymer compositions. The invention also relates to plasticized polymer compositions comprising such carbohydrate and polyol e...
|
|
WO/2003/059924A1 |
The present application describes a binding epitope to Helicobacter pylori, namely substances comprising the oligosaccharide sequence -Gal(Nac)r2&dollar g(b)4Glc(A)q2(Nac)r3-, and the use thereof in pharmaceutical and nutritional composi...
|
|
WO/2003/059359A1 |
There is disclosed a method for disrupting biofilm and for inhibiting biofilm formation in an aqueous environment that comprises contacting said environment with an effective amount of D-tagatose.
|
|
WO/2003/056038A1 |
The invention relates to a chromatographic separation process of recovering mannose with high purity. The invention is based on the use of a chromatographic separation resin including a resin which is at least partly in a Ba?2+¿ form re...
|
|
WO/2003/046194A1 |
Novel &agr -galactosyl-containing non-reducing disaccharides Gal&agr 1-1βGal and Gal&agr 1-1βGlc expected as useful food materials and medicinal materials which would not damage amino acids or proteins when added to foods or preserved....
|
|
WO/2003/044032A1 |
A sugar derivative which has altered properties of a cyclic tetrasaccharide so as to expand the range of applications of the compound represented by the chemical formula (1); a composition containing the derivative; and a process for pro...
|
|
WO/2003/040185A2 |
The invention relates to monoclonal antibodies which specifically bind to glycoproteins that comprise N-glycan chains with a terminal glycosidically bound N-glycolyl neuraminic acid and to hybridoma cells that produce antibodies of this ...
|
|
WO/2003/037906A1 |
The present invention provides use in medicine of a cyclic compound having Formula (I), or a derivative thereof, wherein R?1¿ and R?2¿ are independently selected from -OH,=O, and OR', wherein R' is H or -COR'', and R'' is C¿1-10?alkyl...
|
|
WO/2003/035656A1 |
The described invention relates to the new compound 'sucrose octosulphate salified with silver' usefully applicable in the prevention and cure of infections by micro−organisms of bacterial, fungal, viral and&sol or of yeast origins and...
|
|
WO/2003/033003A1 |
It is intended to provide an agent controlling the production of an osteoclast formation regulator and a method of screening a substance capable of controlling the production of an osteoclast formation regulator. Namely, an agent control...
|
|
WO/2003/031043A1 |
The invention relates to the use as surfactant, for the preparation of dispersions of multiphase systems that comprise a continuous aqueous phase containing a high concentration of electrolytes, of hydrophobically modified saccharides of...
|
|
WO/2003/022860A1 |
Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
|
|
WO/2003/020735A1 |
The invention relates to methods for the sulfation of saccharides. In particular, the invention relates to methods for the sulfation of low molecular weight saccharides derived from glycosaminoglycans.
|
|
WO/2003/017949A2 |
Novel synthetic gangliosides and pharmaceutical compositions containing such synthetic gangliosides are described. Methods of making the novel synthetic ganglioside compounds and compositions as well as their use in the field of neuropro...
|
|
WO/2003/018597A1 |
It is intended to provide a powder comprising water−containing β−maltose crystals, which has been powdered by spraying and is excellent in the solubility in an aqueous system and handling properties, a process for producing the same...
|
|
WO/2003/016915A1 |
The present invention describes oligosaccharide sequences, which are specifically expressed by human tumors. The present inventionis related to a method of determining an oligosaccharide sequence, which comprises a tumor specific termina...
|
|
WO/2003/016325A1 |
A modified metal ion compound reduced in industrially undesirable properties inherent in metal ion compounds, such as deliquescence, reducing ability, oxidizing ability, and poor solubility in water&semi a process for producing the produ...
|
|
WO/2003/010339A1 |
Disclosed is a process of chromatographically separating a material comprising a mixture of sugars, primarily xylose and glucose, into separate streams, one enriched in glucose and another enriched in xylose. In one preferred embodiment,...
|
|
WO/2003/004507A1 |
The invention involves a kind of oligosaccharides and their sulfates. The backbone of the oligosaccharides is consisting of 3 to 14 sugar residues, and the side chains are consisting of 0 to 4 sugar residues. There is at least one 1 →$...
|
|
WO/2002/103008A2 |
The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of...
|
|
WO/2002/103038A1 |
The invention relates to an enzymatic method of producing 4-0-$g(b)-D-galactopyranosyl-D-xylose which is used for the in vivo evaluation of intestinal lactase activity in humans. The inventive method consists in: a) reacting D-xilose wit...
|
|
WO/2002/091859A1 |
The invention provides an agent that heightens concentration and attentiveness and sustains concentration and attentiveness for a longer period of time and more constantly. It also provides food and drink that contains the agent that sus...
|
